全文获取类型
收费全文 | 43884篇 |
免费 | 4939篇 |
国内免费 | 674篇 |
专业分类
耳鼻咽喉 | 281篇 |
儿科学 | 583篇 |
妇产科学 | 969篇 |
基础医学 | 2303篇 |
口腔科学 | 1359篇 |
临床医学 | 9739篇 |
内科学 | 4211篇 |
皮肤病学 | 569篇 |
神经病学 | 1990篇 |
特种医学 | 722篇 |
外国民族医学 | 9篇 |
外科学 | 7112篇 |
综合类 | 6020篇 |
现状与发展 | 3篇 |
一般理论 | 7篇 |
预防医学 | 4824篇 |
眼科学 | 276篇 |
药学 | 4491篇 |
46篇 | |
中国医学 | 2163篇 |
肿瘤学 | 1820篇 |
出版年
2024年 | 48篇 |
2023年 | 1131篇 |
2022年 | 1001篇 |
2021年 | 2022篇 |
2020年 | 2215篇 |
2019年 | 2311篇 |
2018年 | 2122篇 |
2017年 | 2018篇 |
2016年 | 1745篇 |
2015年 | 1892篇 |
2014年 | 3288篇 |
2013年 | 3653篇 |
2012年 | 2621篇 |
2011年 | 2677篇 |
2010年 | 2257篇 |
2009年 | 2097篇 |
2008年 | 2113篇 |
2007年 | 2042篇 |
2006年 | 1826篇 |
2005年 | 1646篇 |
2004年 | 1296篇 |
2003年 | 1114篇 |
2002年 | 953篇 |
2001年 | 767篇 |
2000年 | 618篇 |
1999年 | 522篇 |
1998年 | 433篇 |
1997年 | 330篇 |
1996年 | 300篇 |
1995年 | 279篇 |
1994年 | 261篇 |
1993年 | 231篇 |
1992年 | 172篇 |
1991年 | 166篇 |
1990年 | 154篇 |
1989年 | 141篇 |
1988年 | 127篇 |
1987年 | 108篇 |
1986年 | 103篇 |
1985年 | 133篇 |
1984年 | 116篇 |
1983年 | 92篇 |
1982年 | 97篇 |
1981年 | 71篇 |
1980年 | 64篇 |
1979年 | 37篇 |
1978年 | 24篇 |
1977年 | 15篇 |
1976年 | 15篇 |
1975年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
目的 探讨电针复合靶控输注(Target Controlled Infusion, TCI)在单肺通气食管癌开胸手术麻醉中的应用价值。方法 选取于我院拟行单肺通气食管癌开胸切除手术患者60例作为研究对象。随机将其分为试验组与对照组,对照组30例采取气管插管全麻及TCI靶控输注维持麻醉深度,试验组30例则在对照组方案基础上辅助电针麻醉,记录两组患者手术麻醉时间、药物用量、苏醒时间、并发症;以及术前(TⅠ)、插管前即刻(TⅡ)、插管后1 min(TⅢ)、切皮即刻(TⅣ)、去骨时(TⅤ)、拔管即刻(TⅥ)时平均动脉压(MAP)、平均心率(HR)、BIS值;术前、术后1天、术后3天简易智能精神状态检查量表(MMSE);并于麻醉诱导前(T0)、手术开始2 h(T1)、术后1天(T2)、术后3天(T3)时抽取患者外周静脉血检测IL-1β、IL-6、IL-10、TNF-α浓度。结果 试验组手术用时、麻醉时间略低于对照组,但差异无统计学意义(P>0.05),试验组异丙酚、舒芬太尼用量以及苏醒时间均明显低于对照组(P<0.05);TⅡ时两组平均动脉压(Mean Arterial Pressure, MAP)、心率(Heartrate, HR)较术前明显降低,且试验组MAP明显低于对照组(P<0.05),但两组TⅡ时HR比较无显著差异(P>0.05);TⅢ、TⅥ时对照组MAP、HR明显高于TⅠ时,而试验组MAP、HR与TⅠ比较无显著差异(P>0.05)。术后1天、3天试验组简易智能精神状态检查量表(Mini-Mental State Examination, MMSE)评分低于对照组,有显著性差异(P<0.05)。T1、T2、T3时试验组白介素-1β(IL-1β)、白介素-6(IL-6)、肿瘤坏死因子(Tumor Necrosis Factor-α, TNF-α)水平明显低于对照组(P<0.05),白介素-10(IL-10)水平明显高于对照组(P<0.05)。结论 采用电针复合TCI靶控输注麻醉方案可有效提升单肺通气食管癌开胸手术麻醉效果,能够降低患者术后认知功能障碍发生风险。 相似文献
82.
83.
E. Albrecht D. Capel J. B. Rossel M. R. Wolmarans A. Godenèche D. De Paulis J. Cabaton 《Anaesthesia》2023,78(3):315-319
Prolongation of peripheral nerve blockade by intravenous dexamethasone may be extended by intravenous dexmedetomidine. We randomly allocated 122 participants who had intravenous dexamethasone 0.15 mg.kg−1 before interscalene brachial plexus block for day-case arthroscopic rotator cuff repair to intravenous saline (62 participants) or intravenous dexmedetomidine 1 μg.kg−1 (60 participants). The primary outcome was time from block to first oral morphine intake during the first 48 postoperative hours. Fifty-nine participants reported taking oral morphine, 25/62 after placebo and 34/60 after dexmedetomidine, p = 0.10. The time to morphine intake was shorter after dexmedetomidine, hazard ratio (95%CI) 1.68 (1.00–2.82), p = 0.049. Median (IQR [range]) morphine doses were 0 (0–12.5 [0–50]) mg after control vs. 10 (0–30 [0–50]) after dexmedetomidine, a difference (95%CI) of 7 (0–10) mg, p = 0.056. There was no effect of dexmedetomidine on pain at rest or on movement. Intra-operative hypotension was recorded for 27/62 and 50/60 participants after placebo vs. dexmedetomidine, respectively, p < 0.001. Other outcomes were similar, including durations of sensory and motor block. In conclusion, dexmedetomidine shortened the time to oral morphine consumption after interscalene block combined with dexamethasone and caused intra-operative hypotension. 相似文献
84.
85.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
86.
目的:比较两种家庭训练方案对腰痛患者的临床疗效。方法:门诊招募60例腰痛患者随机分为常规组(n=30)和核心组(n=30)。两组患者均接受腰痛防护知识宣教及评估。常规组接受常规家庭训练方案指导;核心组接受麦吉尔(McGill)"三大训练"(Big3)家庭方案指导。之后两组患者独立完成6周家庭训练。训练前后采用汉化Oswestry功能障碍指数(Oswestry disability index,ODI)和疼痛目测类比定级法(visual analogus scale,VAS)作为主要评估指标,腰部活动度和躯干肌群的肌耐力作为次要评估指标对患者治疗效果进行评估。根据患者训练的完成度、自觉帮助度及满意度评估患者治疗依从性及家庭训练方案的可行性。结果:常规组和核心组分别有24例和25例完成了家庭训练。经过6周家庭训练后,两组患者的ODI及VAS均有明显降低(P<0.01)、腰部ROM均有明显增加(P<0.01);常规组部分躯干肌群和核心组全部躯干肌群的肌耐力明显增强(P<0.01);核心组的ODI、VAS和右侧侧方肌的肌耐力与常规组比较差异具有显著性意义(P<0.05);核心组患者的自觉帮助度及满意度得分与常规组比较差异具有显著性意义(P<0.01)。结论:两种腰痛家庭训练方案均可行并有效。与常规家庭训练方案相比,Big3家庭训练方案对于改善腰痛患者疼痛和功能障碍方面具有更好的临床疗效,并且患者的接受度更高。 相似文献
87.
88.
89.
90.
Up to 40% of dementias may be preventable via risk factor modification. This inference has motivated the development of lifestyle interventions for reducing cognitive decline. Typically delivered to older adults face-to-face, the COVID-19 pandemic has necessitated their adaptation for remote delivery. We systematically reviewed randomized controlled trials of remotely delivered lifestyle interventions (≥4 weeks duration and delivered >50% remotely), for adults aged ≥ 60 without dementia, examining effects on objective cognitive measures. Comparators were active (face-to-face or remote) or passive. Ten studies (n = 2967) comprising multidomain (k = 4), physical activity (k = 3) or psychosocial (k = 3) remote interventions were included. Data were synthesized using robust variance estimation meta-analysis. The pooled estimate comparing the effect of remote interventions versus comparators on cognition was not significant (g=−0.02; 95%CI [−0.14, 0.09]; p = .66); subgroup analyses by type of intervention or comparator also yielded non-significant effects. Most studies had low risk of bias. Current evidence to support remote lifestyle interventions is limited. Included studies were conducted pre-pandemic, and evaluated individual, rather than group interventions. Future studies may exploit the greater digital connectivity of older people since the pandemic. Group formats, more frequently efficacious than individual interventions in face-to-face dementia prevention trials, may be a rational approach for future remote trials. 相似文献